Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 1998
Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra Thoraciques
I Monnet, S Brienza, F Hugret, et al.
European Journal of Haematology. Supplementum
|
January 1, 1987
Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia
D Machover, J Gastiaburu, M Delgado, et al.
Anticancer Research
|
January 1, 1982
Treatment of lymphoid neoplasias with interferon. II. Human leucocyte alpha-interferon in chronic lymphatic leukemia (CLL). PHase I-II trial
J L Misset, G Mathé, J Gastiaburu, et al.
Anticancer Research
|
January 1, 1982
Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial
J L Misset, G Mathé, J Gastiaburu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1982
[Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route]
J L Misset, G Mathé, J Gastiaburu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1982
[Treatment of leukemias and lymphomas with interferons: I. Trial of myeloma therapy with human beta-interferon]
J L Misset, G Mathé, J Gastiaburu, et al.
La Nouvelle Presse Medicale
|
January 9, 1982
[Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)]
G Mathé, R de Jager, R Hulhoven, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1996
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
D Machover, E Diaz-Rubio, A de Gramont, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 1998
Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra Thoraciques
I Monnet, S Brienza, F Hugret, et al.
European Journal of Haematology. Supplementum
|
January 1, 1987
Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia
D Machover, J Gastiaburu, M Delgado, et al.
Anticancer Research
|
January 1, 1982
Treatment of lymphoid neoplasias with interferon. II. Human leucocyte alpha-interferon in chronic lymphatic leukemia (CLL). PHase I-II trial
J L Misset, G Mathé, J Gastiaburu, et al.
Anticancer Research
|
January 1, 1982
Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial
J L Misset, G Mathé, J Gastiaburu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1982
[Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route]
J L Misset, G Mathé, J Gastiaburu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1982
[Treatment of leukemias and lymphomas with interferons: I. Trial of myeloma therapy with human beta-interferon]
J L Misset, G Mathé, J Gastiaburu, et al.
La Nouvelle Presse Medicale
|
January 9, 1982
[Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)]
G Mathé, R de Jager, R Hulhoven, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1996
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
D Machover, E Diaz-Rubio, A de Gramont, et al.
Page
of 2